Guidance for 2026 is for 5.4% midpoint revenue growth and 9% adjusted EPS growth, compared to 2025's 7% revenue and 13% EPS ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) fell short of the market’s revenue expectations in Q4 CY2025, but ...

The addition of Scott to the Fortrea team while Oren becomes fully dedicated to the medical and scientific aspects of development is a win for clients,” said Anshul Thakral, CEO. “Working closely with ...

Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, banking on robust demand ...

It's not the only name in the business, to be clear. Recursion Pharmaceuticals and AbCellera Biologics are a couple of other names offering AI-powered drug discovery solutions as well, along with a ...

The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...

CAMBRIDGE, Mass., February 12, 2026 - Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the launch of a new interactive webpage highlighting ...

Elecsys® pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathologyNow available nationwide in ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an ...

TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...

Headquartered in Northwood, Ohio, Namsa provides medical device testing, clinical research and regulatory consulting to medtech companies This acquisition is Namsa’s 10 th acquisition since becoming ...